Met de LIFE Cooperative naar Basel voor de BIO Europe

The Dutch brothers Martijn and Winant Zwinderman, CEO and CFO of Griphingo Pharmaceuticals, attended the BIO-Europe conference to update fellow biotech entrepreneurs, consultants and investment firms on the latest developments of Griphingo’s HDAC inhibitors for the treatment of chronic obstructive pulmonary disease. At the Champions League for life science companies, business relationships were built and nurtured to create win-win possibilities for further progress. As Griphingo states: “BIO-Europe offers the opportunity to learn from other start-ups and get in touch with investors, consultants and contract research organizations, crucial for the successful development of our new treatment option. We strongly feel that the contacts we made, the information we collected and the insight we gained, motivates the participation costs. We recommend other start-ups to participate in the upcoming Bio-Europe in Munich (November 6-8, 2023).

BIO-Europe Spring hosted over 19,000 one-to-one partnering meetings that connected leaders from academia, start-up, and scale-up biotech companies with forward-thinking investors and pharma companies. Along with world-class workshops and panels, innovative company presentations, active exhibitors, and a variety of networking opportunities the conference is an unrivalled forum for companies across the biotech value chain to meet and do business.